This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy Manufacturing & Commercialization Europe

£500 Savings Expires In

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
Conference: 4-7 Dec 2023 | Exhibition: Dec 5-6 2023
Convention Centre DublinDublin, Ireland

THE EUROPEAN CELL AND GENE THERAPY CONGRESS FOR GROUNDBREAKING MANUFACTURING, COMMERCIALISATION & ANALYTICAL STRATEGIES

World renowned leaders share the latest process development, analytical and market access strategies to improve manufacturing scalability, quality and cost to propel your CGT programmes to commercial success

400+ Global Attendees · 50+ Exhibitors · 30+ Scientific Posters · 3 Conference Tracks

THREE TRACKS TO BRING YOU CUTTING EDGE CASE STUDIES TO IMPROVE EFFICIENCIES IN CELL & GENE THERAPY PRODUCTION

Cell Therapy Manufacturing & Analytics

  • Gain industry insights on process development strategies to reduce cost of good and increase access to patients for autologous and allogeneic cell therapies
  • Discover process optimisation and implementation strategies for automated, closed, and integrated systems in cell therapy manufacturing
  • Build your analytical toolbox to improve testing, characterisation & validation strategies
  • Overcome the scale up and manufacturing challenges of next generation “off the shelf” allogeneic and gene edited modalities

Gene Therapy Manufacturing & Analytics

  • Hear case studies on how to increase speed, consistency, scalability, and flexibility in gene therapy manufacturing for rare diseases and beyond
  • Develop analytical toolkits for AAV characterisation, process comparability, understanding CQAs and beyond empty vs full
  • Discuss improvement and innovations in cell line development and upstream processing to increase yields and process productivity
  • Evaluate new technologies to overcome downstream processing and viral clearance bottlenecks

CGT Partnering and Commercialisation

  • Gain exclusive insights from industry experts on maximizing value in CGT partnerships, navigating research uncertainty, and leveraging AI for predicting durability.
  • Learn about commercial challenges and opportunities in ex vivo vs. in vivo approaches, including strategies for cost and logistical challenges.
  • Understand innovative pricing, payment strategies, and successful commercial launch practices from recent CGT approvals.
  • Explore evolving partnership dynamics and impacts of market conditions on CGT collaborations, fostering future relationships.
  • Get investor perspectives on CGT trends to aid future collaborations with VC and private equity firms.

Cell & Gene Therapy Manufacturing & Commercialization Europe by the Numbers

400+

Global Attendees

50+

Exhibitors

30+

Scientific Posters

CONNECT WITH KEY BUYERS AT CELL & GENE THERAPY EUROPE 2023

Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals. Contact us today to learn more: Partners@informaconnectls.com